Different cellular signaling pathways are known to modulate the response to radiotherapy in endometrial cancer, including the PI3K/AKT and NF-κB pathways, in association with DNA damage repair mechanisms and the immune system [69]. The gene discussed is NFKB1; the disease is endometrial cancer.